RE:RE:RE:RE:Market Slaughterwithout sounding like a sarcastic d!ck, do you really want these guys focused or more than one thing at a time? The goal now should be attaining North American biotech's second most disrespected valuation and move up from there. A 5 bagger from here will value them with some less promising P1 companies. That should be the all hands on deck focus. Other than generating the attention and respect of a chain smoker at a triathlon, they are doing a great job.